Your browser doesn't support javascript.
loading
The discovery of hypoglycaemic sulphonamides - Montpellier, 1942.
Lavabre-Bertrand, Thierry; Faillie, Jean-Luc.
Affiliation
  • Lavabre-Bertrand T; Laboratoire de cytologie clinique et cytogénétique, faculté de médecine, université de Montpellier, CHU de Nîmes, 30029 Nîmes cedex 9, France. Electronic address: thierry.lavabre.bertrand@chu-nimes.fr.
  • Faillie JL; Département de pharmacologie médicale et toxicologie, centre régional de pharmacovigilance Occitanie-Est, CHU de Montpellier, Institut Desbrest d'épidémiologie et de santé publique, université de Montpellier, Inserm, 34000 Montpellier, France.
Therapie ; 76(6): 559-566, 2021.
Article in En | MEDLINE | ID: mdl-34656290
ABSTRACT
The pathophysiological study of diabetes mellitus took an important place in the school of Montpellier since the end of the XIXth century with Emmanuel Hedon's (1863-1933) contribution to the demonstration of the endocrine function of the pancreas. In 1942, a new sulfonamide compound (2254RP) was tested in the infectious diseases department of Pr M. Janbon (1898-1996) on cases of typhoid fever, leading to several deaths rapidly related to hypoglycaemia. The physiologist Auguste Loubatières (1912-1977) rapidly demonstrated that this hypoglycaemic effect required the presence of pancreas and was explained by stimulation of insulin secretion. He contributed to the description of a hypoglycaemic effect of several other sulphonamide compounds. He considered the diagnostic and therapeutic relevance of this class of drugs. This is a good example of a medical discovery combining a favourable local environment, serendipity and perfect experimental approach.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Diabetes Mellitus / Diabetes Mellitus, Type 2 / Hypoglycemia Limits: Humans / Male Language: En Journal: Therapie Year: 2021 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Diabetes Mellitus / Diabetes Mellitus, Type 2 / Hypoglycemia Limits: Humans / Male Language: En Journal: Therapie Year: 2021 Document type: Article